SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

書誌詳細
第一著者:	Meem, Manila
その他の著者:	Akter, Dr. Raushanara
フォーマット:	学位論文
言語:	English
出版事項:	Brac University 2023
主題:	Cancer SHP2 inhibitors Targeted therapy Catalytic inhibitor Allosteric inhibitor. Cancer research.
オンライン･アクセス:	http://hdl.handle.net/10361/18081

類似資料

A review on potential of PARP inhibitors in the treatment of prostate cancer
著者:: Islam, Saidul
出版事項: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
著者:: Jahan, Nusrat
出版事項: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Flora, Sanzida Alam
出版事項: (2024)

Immunotherapy in the Management of Lung Cancer
著者:: Tasnim, Humayra
出版事項: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
著者:: Ratu, Tabassum
出版事項: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
著者:: Emon, Kamrul Hasan
出版事項: (2022)

Identification of FAP inhibitors using in silico simulation study
著者:: Deeba, Maliha Tasnim
出版事項: (2018)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
著者:: Oshin, Sadia Afrin
出版事項: (2021)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
著者:: Karim, Azrin
出版事項: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
著者:: Mirza, Maisa Tasnim
出版事項: (2023)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
著者:: Khan, Muidul Hasan
出版事項: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
著者:: Haque, Mushfiqul
出版事項: (2019)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
著者:: Islam, Nahidul
出版事項: (2023)

A review on targeted therapies for lung cancer
著者:: Ashraf, Anushey
出版事項: (2023)

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
著者:: Afroza, Halima
出版事項: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
著者:: Ishrat, Nowshin
出版事項: (2024)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
著者:: Sorno, Rubina Haque
出版事項: (2024)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
著者:: Mahin, Md. Tamjidur Rahman
出版事項: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
著者:: Alam, Kazi Tasnuva
出版事項: (2022)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
著者:: Fred, Namanda Rogers
出版事項: (2021)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
著者:: Khandker, Tahia Anjum
出版事項: (2024)

Synthesis and sar o acne medication
著者:: Naureen, Tasnia
出版事項: (2024)

HPLC method development for the analysis of linagliptin
著者:: Mimiya, Ruhani Amrin
出版事項: (2020)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
著者:: Paul, Pulock
出版事項: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
著者:: Kamal, Tasnova
出版事項: (2019)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
著者:: Tania, Umme
出版事項: (2023)

Trend in approval of targeted biologics in the last two decades
著者:: Siddika, Khadiza
出版事項: (2024)

Breast cancer therapy through Liposomal drug delivery system
著者:: Ome, Nusrat Jahan
出版事項: (2024)

Epigenetic therapy in cancer
著者:: Abid, Md. Shadman Ridwan
出版事項: (2021)

A review on triple-negative breast cancer and its potential treatment
著者:: Niasa, Jannatul Ferdous
出版事項: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
著者:: Razna, Amrin Islam
出版事項: (2019)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
著者:: Chakraborty, Anuradha
出版事項: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
著者:: Nahar, Kamrun
出版事項: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
著者:: Nashrah, Zannatul
出版事項: (2023)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
著者:: Hoque, Syeda Mehren
出版事項: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
著者:: Parvez, Safi
出版事項: (2023)

Statistics and informatics in molecular cancer research

A comprehensive review on drug repurposing in cancer treatment
著者:: Sarkar, Onusree
出版事項: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
著者:: Hasan, Amit
出版事項: (2024)

Art therapy to improve quality of life of cancer patients and their carers in Bangladesh
著者:: Dowla, Rumana, 等
出版事項: (2022)